Novartis Suspends Eight CAR-T Studies After Patient Deaths Trigger Safety Review
As reported in the European Medical Journal, Novartis has paused eight clinical studies evaluating its experimental CAR-T cell therapy, known as rap-cell, after three trial participants died following severe immune-related…
Continue Reading
Novartis Suspends Eight CAR-T Studies After Patient Deaths Trigger Safety Review
